Eli Lilly and Company announced this month that they’re reducing the price of their most common insulin by 70% and capping patient out-of-pocket insulin costs at $35 or less a month. It might make cynical people wonder why. But in spite of how things feel these days, the overall arch of society in the U.S. seems to be bending toward shared value, social good and trust. And it just might be being demonstrated every day at the ballpark.